thiazoles has been researched along with ATLL in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asada, H; Miyagawa, F; Miyao, M; Nishikawa, M; Ogawa, K; Yamamoto, S | 1 |
Cools, J; Cortes, J; Garcia-Manero, G; Gilliland, DG; Kantarjian, H; Lee, F; Lennon, PA; Manshouri, T; Quintás-Cardama, A; Tong, W; Vega, F | 1 |
Haber, M; Madafiglio, J; Norris, MD | 1 |
Balog, A; Bertino, JR; Chou, TC; Danishefsky, SJ; Harris, CR; Kuduk, SD; Savin, KA; Zhang, XG | 1 |
Jansen, G; Kaspers, GJ; Mauritz, R; Noordhuis, P; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ | 1 |
5 other study(ies) available for thiazoles and ATLL
Article | Year |
---|---|
Predisposition to multi-drug hypersensitivity after administration of mogamulizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Diuretics; Drug Eruptions; Esomeprazole; Factor Xa Inhibitors; Fatal Outcome; Female; Furosemide; Humans; Immunologic Factors; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Proton Pump Inhibitors; Pyridines; Thiazoles; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.
Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Dasatinib; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Male; Mice; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor; Thiazoles; Tumor Cells, Cultured | 2008 |
Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.
Topics: Coloring Agents; Culture Media; Drug Screening Assays, Antitumor; Humans; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Tetrazolium Salts; Thiazoles; Thymidine Phosphorylase; Tumor Cells, Cultured; Xanthine Oxidase | 1993 |
Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Resistance, Neoplasm; Epothilones; Female; Humans; Lactones; Leukemia P388; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Structure-Activity Relationship; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folic Acid Antagonists; HL-60 Cells; Humans; Infant; Infant, Newborn; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Neoplasm Proteins; Neoplastic Stem Cells; Polyglutamic Acid; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sensitivity and Specificity; Staining and Labeling; Tetrazolium Salts; Thiazoles; Thymidylate Synthase; U937 Cells | 1999 |